Beam Therapeutics Inc. Banner Image

Beam Therapeutics Inc.

  • Ticker BEAM
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Beam Therapeutics Inc. Logo Image
  • 201-500 Employees
  • Based in Cambridge, Massachusetts
Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company developing precision genetic medicines through the use of base editing. Beam’s proprietary base editors create precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This enables a wide range of potential therapeutic editing strategies that Beam isMore using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
4.8 / 5.0 (236)

Beam Therapeutics Inc. reports have an aggregate usefulness score of 4.8 based on 236 reviews.

Beam Therapeutics Inc.

Most Recent Annual Report

Beam Therapeutics Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Beam Therapeutics Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!